Recent Quotes (30 days)

You have no recent quotes
chg | %

Pyng Medical Corp  

(Public, CVE:PYT)   Watch this stock  
Find more results for PYT
0.0000 (0.00%)
May 2 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.02 - 0.10
Open     -
Vol / Avg. 0.00/2,213.00
Mkt cap 1.42M
P/E     -
Div/yield     -
EPS -0.01
Shares 28.48M
Beta -0.98
Inst. own     -
May 24, 2016
Q2 2016 Pyng Medical Corp Earnings Release (Estimated) Add to calendar

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -43.45% 0.07%
Operating margin -34.75% 6.93%
EBITD margin - 11.49%
Return on average assets -32.65% 0.09%
Return on average equity -59.78% 0.16%
CDP Score - -


Suite 210 - 13480 Crestwood Place
+1-604-3037964 (Phone)
+1-604-3037987 (Fax)

Website links


Pyng Medical Corp. (Pyng) engineers and markets trauma and resuscitation products for frontline critical care personnel. The Company's product portfolio includes sternal intraosseous (sternal IO), pelvic stabilization and tourniquet devices designed and customized for both the military and civilian markets. It develops medical devices for use by hospital staff, emergency medical services and military forces. It has developed and commercialized an intraosseous (IO) infusion system, FAST1 Intraosseous Infusion System, which provides vascular access to enable the administration of drugs, medications, fluids and blood that require emergency life-saving treatment. FASTResponder and FASTCombat provide fluids, medication and blood. The T-POD Pelvic Stabilization devices provide treatment of pelvic fractures. The MAT Tourniquet is applied by the wounded patient to stop life threatening bleeding. The CRIC is a life-saving medical product allowing for surgical airway intervention.

Officers and directors

Ronald Ray Blanck Independent Chairman of the Board
Mark F. Hodge President, Chief Executive Officer
George G. Dorin Chief Financial Officer, Corporate Secretary
Age: 62
Robert Di Silvio Director
Age: 61
Alan L. Moloff Director
Herbert A. Toms III Director
Llewellyn J. Evans Jr. Independent Director